The GNS Knockout HAP1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population engineered to disrupt the GNS gene in the HAP1 human haploid cell line. This product provides a heterogeneous pool of cells carrying loss-of-function mutations in the target locus, enabling robust investigation of N-acetylglucosamine-6-sulfatase function without the need for single-cell clone isolation. The polyclonal format preserves genetic diversity while ensuring effective gene disruption across the population, making it suitable for population-level phenotypic analyses, drug response assays, and pathway dissection studies. By leveraging the CRISPR/Cas9 system, the GNS locus is specifically targeted, generating a reliable model of GNS deficiency.
The HAP1 cell line is a near-haploid human cell line derived from the chronic myeloid leukemia cell line KBM-7. It exhibits an adherent, fibroblast-like morphology and retains a single copy of most chromosomes, which simplifies genetic manipulation and facilitates complete gene knockout without the complication of a second allele. HAP1 cells are widely employed in functional genomics, genetic screening, and signaling research due to their ease of culture, stable karyotype in haploid state, and susceptibility to CRISPR/Cas9 editing. Their hematopoietic origin and dispensable p53 function also contribute to their utility in cancer biology and DNA damage response studies, providing a versatile background for interrogating lysosomal enzyme deficiencies.
GNS encodes N-acetylglucosamine-6-sulfatase, a lysosomal enzyme that catalyzes the hydrolysis of 6-sulfate groups from terminal N-acetylglucosamine residues in heparan sulfate and keratan sulfate glycosaminoglycans. Its activity is strictly dependent on post-translational modification by sulfatase-modifying factor 1 (SUMF1), which activates the catalytic cysteine residue. Transcription of GNS is regulated by the master lysosomal/autophagy transcription factor TFEB, linking its expression to lysosomal biogenesis and stress responses. Loss of GNS function leads to intralysosomal accumulation of partially degraded heparan sulfate, which in turn aberrantly influences extracellular signaling pathways, notably Hedgehog and fibroblast growth factor (FGF) signaling, through disrupted interactions with heparan sulfate proteoglycans. Other sulfatases, such as iduronate 2-sulfatase and N-sulfoglucosamine sulfohydrolase, act upstream in the same catabolic pathway, while ??-N-acetylglucosaminidase processes desulfated substrates downstream, highlighting the coordinated nature of glycosaminoglycan degradation.
In the HAP1 background, GNS knockout generates a powerful model to study the cellular consequences of mucopolysaccharidosis type IIID (Sanfilippo D syndrome). The haploid nature of HAP1 cells ensures that CRISPR/Cas9-mediated gene disruption results in a uniform loss-of-function phenotype across the polyclonal population, eliminating concerns of heterozygous masking. This system enables direct correlation between genotype and lysosomal storage phenotype, including accumulation of heparan sulfate fragments and secondary lysosomal dysfunction. Researchers can utilize this model to dissect TFEB-mediated compensatory responses, evaluate SUMF1-dependent sulfatase activation, and quantify altered Heparan sulfate-dependent signaling outputs, such as Hedgehog pathway activity, in a tractable human cell system.
This GNS knockout polyclonal cell population is ideally suited for a wide range of biomedical research applications, including mechanistic studies of glycosaminoglycan metabolism, lysosomal storage disease modeling, and high-throughput drug screening for mucopolysaccharidosis type IIID. Typical experimental approaches include western blotting to confirm GNS protein loss, fluorogenic enzyme activity assays to quantify residual sulfatase activity, LC-MS-based heparan sulfate profiling to assess metabolite accumulation, and immunofluorescence staining for lysosomal markers (e.g., LAMP1) to visualize lysosomal expansion. Additionally, the model facilitates investigation of crosstalk between lysosomal stress signaling and developmental pathways, particularly the impact of heparan sulfate on Hedgehog morphogen gradient formation and FGF receptor binding. For further information or technical support regarding this product, please contact Ascent Research.
